Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis–Related Interstitial Lung Disease (Scleroderma Lung Study <scp>III</scp> ): An Investigator‐Initiated, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
Dinesh Khanna(University of Michigan), Marcin A. Trojanowski(Boston University), Gary M. Hunninghake(Hubei University of Science and Technology), Mary Beth Scholand(University of Utah), Ganesh Raghu(University of Washington), Maureen D. Mayes(The University of Texas Health Science Center), Richard McLain(University of Michigan), R. Boente(Indiana University School of Medicine), Jane E. Dematte(Northwestern University), Eric C. Kleerup, Iván O. Rosas(Brigham and Women's Hospital), Aryeh Fischer(University of Colorado Denver), Cathie Spino(University of Michigan), Jonathan Goldin(UCLA Health), Elana J. Bernstein(Columbia University), Virginia Steen(Georgetown University), Airi Harui(University of California, Los Angeles), Vivien Hsu(Rutgers, The State University of New Jersey), Donald P. Tashkin(University of California, Los Angeles), Vivek Nagaraja(Mayo Clinic in Arizona), Grace Hyun J. Kim(APLA Health), Paul F. Dellaripa(Brigham and Women's Hospital), Robyn T. Domsic(University of Pittsburgh), Jessica Gordon(Hospital for Special Surgery), Richard M. Silver(Medical University of South Carolina), Robert W. Simms(Dartmouth–Hitchcock Medical Center), Grace Ibrahim(University of California, Los Angeles), Joyce Lee(Inserm), Suiyuan Huang(University of Michigan), Yi‐Hsuan Tu(University of Michigan), Michael D. Roth(Johns Hopkins University), S. Samuel Weigt(University of California, Los Angeles)
Cited by 3
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k